Found: 27
Select item for more details and to access through your institution.
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 10, p. 2523, doi. 10.1007/s00520-011-1375-6
- By:
- Publication type:
- Article
Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression-Free Survival on First-Line Therapy Predicts Overall Survival Impact.
- Published in:
- Breast Journal, 2014, v. 20, n. 4, p. 408, doi. 10.1111/tbj.12284
- By:
- Publication type:
- Article
Adjuvant Trastuzumab for Breast Cancer Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 5, p. 361, doi. 10.2165/11588350-000000000-00000
- By:
- Publication type:
- Article
Isolated metastasis to the cerebellopontine angle secondary to breast cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Isolated metastasis to the cerebellopontine angle secondary to breast cancer.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
INVASIVE BREAST CARCINOMAS WITH EQUIVOCAL HER2 IN SITU HYBRIDIZATION TEST RESULTS: AN ONGOING CHALLENGE FOR PATHOLOGISTS AND ONCOLOGISTS.
- Published in:
- Canadian Journal of Pathology, 2017, v. 9, n. 4, p. 30
- By:
- Publication type:
- Article
Nurse Navigators' Views on Patient and System Factors Associated with Navigation Needs among Women with Breast Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 3, p. 2107, doi. 10.3390/curroncol28030195
- By:
- Publication type:
- Article
Length of Survival in Hospice for Cancer Patients Referred From a Comprehensive Cancer Center.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2009, v. 26, n. 4, p. 281, doi. 10.1177/1049909109333928
- By:
- Publication type:
- Article
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 3, p. 743, doi. 10.1007/s10549-021-06164-0
- By:
- Publication type:
- Article
The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 2, p. 357, doi. 10.1007/s10549-018-05114-7
- By:
- Publication type:
- Article
Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 1, p. 191, doi. 10.1046/j.1365-2141.2003.04245_2.x
- By:
- Publication type:
- Article
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 179, doi. 10.4137/CMO.S6460
- By:
- Publication type:
- Article
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 179, doi. 10.4137/CMO.S6460
- By:
- Publication type:
- Article
Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations.
- Published in:
- International Journal of Women's Health, 2014, v. 6, p. 509, doi. 10.2147/IJWH.S47357
- By:
- Publication type:
- Article
Length of Survival of Patients with Cancer in Hospice: A Retrospective Analysis of Patients Treated at a Major Cancer Center Versus Other Practice Settings.
- Published in:
- Journal of Palliative Medicine, 2007, v. 10, n. 2, p. 381, doi. 10.1089/jpm.2006.0071
- By:
- Publication type:
- Article
Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2007, v. 176, n. 3, p. 327, doi. 10.1503/cmaj.060825
- By:
- Publication type:
- Article
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 1115, doi. 10.1007/s10549-012-1989-5
- By:
- Publication type:
- Article
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 114, n. 3, p. 579, doi. 10.1007/s10549-008-0034-1
- By:
- Publication type:
- Article
Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 111, n. 2, p. 261, doi. 10.1007/s10549-007-9770-x
- By:
- Publication type:
- Article
Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 105, n. 2, p. 169, doi. 10.1007/s10549-006-9448-9
- By:
- Publication type:
- Article
Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Comparison of Clinical-Pathologic Characteristics and Outcomes of True Interval and Screen-Detected Invasive Breast Cancer Among Participants of a Canadian Breast Screening Program: A Nested Case-Control Study.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 1, p. 27, doi. 10.3816/CBC.2011.n.005
- By:
- Publication type:
- Article
Impact of the 2013 American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as 'equivocal' for HER2 gene amplification by fluorescence in-situ hybridization
- Published in:
- Histopathology, 2015, v. 67, n. 6, p. 880, doi. 10.1111/his.12723
- By:
- Publication type:
- Article